BeOne Medicines
ONC
#649
Rank
NZ$61.79 B
Marketcap
NZ$558.42
Share price
-2.56%
Change (1 day)
57.04%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

BeOne Medicines (ONC) - Net assets

Net assets on the balance sheet as of September 2025 : NZ$7.14 Billion

According to BeOne Medicines's latest financial reports the company has NZ$7.14 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

BeOne Medicines - Net assets on balance sheet (from 2014 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$NZ$5.90 B5.63%
2023-12-31$NZ$5.59 B-18.98%
2022-12-31$NZ$6.90 B-23.1%
2021-12-31$NZ$8.97 B67.43%
2020-12-31$NZ$5.36 B269.14%
2019-12-31$NZ$1.45 B-44.43%
2018-12-31$NZ$2.61 B171.36%
2017-12-31$NZ$0.96 B89.1%
2016-12-31$NZ$0.50 B369.18%
2015-12-31$NZ$0.10 B230.18%
2014-12-31$NZ$32.88 M-169.79%
2013-12-31$-NZ$47.13 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Onconova Therapeutics
ONTX
NZ$10.4 M-99.85%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
NZ$2.25 B-68.38%๐Ÿ‡บ๐Ÿ‡ธ USA